홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,2-Dichloroethane → 2-{4-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-2-oxo-ethyl]-piperidin-1-yl)-4-trifluoromethyl-benzamide

HRID 1455551
인쇄

반응식

HRID 1455551 반응식
C(Cl)CCl.[C:5]([C:8]1[CH:13]=[CH:12][C:11]([C:14]([F:17])([F:16])[F:15])=[CH:10][C:9]=1[N:18]1[CH2:23][CH2:22][CH:21]([CH2:24][C:25](O)=[O:26])[CH2:20][CH2:19]1)(=[O:7])[NH2:6].[F:28][C:29]([F:45])([F:44])[C:30]1[CH:31]=[C:32]([S:40]([NH2:43])(=[O:42])=[O:41])[CH:33]=[C:34]([C:36]([F:39])([F:38])[F:37])[CH:35]=1.CCN(C(C)C)C(C)C>CN(C1C=CN=CC=1)C.CN(C=O)C>[F:39][C:36]([F:37])([F:38])[C:34]1[CH:33]=[C:32]([S:40]([NH:43][C:25](=[O:26])[CH2:24][CH:21]2[CH2:20][CH2:19][N:18]([C:9]3[CH:10]=[C:11]([C:14]([F:15])([F:17])[F:16])[CH:12]=[CH:13][C:8]=3[C:5]([NH2:6])=[O:7])[CH2:23][CH2:22]2)(=[O:42])=[O:41])[CH:31]=[C:30]([C:29]([F:45])([F:28])[F:44])[CH:35]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 111,2-DichloroethaneHCID 81531DiisopropylethylamineHCID 27831653,5-Bis(trifluoromethyl)benzenesulfonamideHCID 68442763[1-(2-Carbamoyl-5-trifluoromethyl-phenyl)-piperidin-4-yl]-acetic acid

생성물 1

HCID 865970972-{4-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-2-oxo-ethyl]-piperidin-1-yl)-4-trifluoromethyl-benzamide

시약·촉매·용매

2
HCID 142844-(Dimethylamino)pyridine촉매HCID 6228Dimethylformamide용매

실험 절차

0.46 g of 2-fluoro-4-(trifluoromethyl)benzamide are added to a suspension of 1.8 g K2CO3 and 0.8 g of piperidin-4-yl acetic acid hydrochloride In 12 ml of DMSO, the mixture obtained is stirred for 4 h at 150°, solvent is evaporated, the evaporation residue obtained is suspended in MeOH and filtrated. The filtrate obtained is concentrated and subjected to chromatography on silica gel. [1-(2-Carbamoyl-5-trifluoromethyl-phenyl)-piperidin-4-yl]-acetic acid is obtained. 300 mg of EDC are added to a solution of 260 mg of [1-(2-carbamoyl-5-trifluoromethyl-phenyl)-piperidin-4-yl]-acetic acid, 230 mg of 3,5-bis-trifluoromethyl-benzenesulfonamide, 200 mg of DIEA and 90 mg of DMAP in 4 ml of DMF. The mixture obtained is stirred for 3 days at RT, solvent is evaporated in vacuo and the evaporation residue obtained is treated with EtAc. The mixture obtained is washed with 1 N HCl, saturated aqueous NaHCO3 solution and brine, dried, concentrated in vacuo and subjected to chromatography on silica gel. 2-{4-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-2-oxo-ethyl]-piperidin-1-yl}-4-trifluoromethyl-benzamide is obtained.

후처리

  1. customThe mixture obtained
  2. customsolvent is evaporated in vacuo
  3. customthe evaporation residue obtained
  4. additionis treated with EtAc
  5. customThe mixture obtained
  6. washis washed with 1 N HCl, saturated aqueous NaHCO3 solution and brine
  7. customdried
  8. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-332ce80768094c38aa3d78fae640c5f7
출처 데이터셋
uspto-grants-2009_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07482462B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트